ClinicalTrials.gov
ClinicalTrials.gov Menu

Proprioceptive Postural Control and Diaphragm Paresis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01505556
Recruitment Status : Unknown
Verified January 2012 by Simon Brumagne, Katholieke Universiteit Leuven.
Recruitment status was:  Not yet recruiting
First Posted : January 6, 2012
Last Update Posted : December 5, 2013
Sponsor:
Collaborator:
Universitaire Ziekenhuizen Leuven
Information provided by (Responsible Party):
Simon Brumagne, Katholieke Universiteit Leuven

Brief Summary:

Proprioceptive weighting changes may explain differences in postural control performance. In addition, the respiratory movement has a disturbing effect on postural balance. Postural balance seems to be impaired in individuals with respiratory disorders. Increased risk of falling is reported in individuals with chronic obstructive pulmonary disease. Besides the essential role of respiration, the diaphragm may also play an important role in the control of the trunk and postural balance.

The aim of the study is to clarify whether proprioceptive postural control is impaired in individuals with diaphragm paresis.


Condition or disease
Proprioceptive Postural Control Respiratory Disorders Chronic Obstructive Pulmonary Disease

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Study Start Date : January 2014
Estimated Primary Completion Date : December 2014
Estimated Study Completion Date : January 2015

Group/Cohort
Diaphragm paresis
Healthy controls



Primary Outcome Measures :
  1. Proprioceptive postural control [ Time Frame: 1 year ]
    Center of pressure displacement (force plate) in standing in response to local muscle vibration on ankle and back muscles to specifically detect the role of proprioception in postural control.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
patients from the University Hospital Leuven - Respiratory Disvision
Criteria

Inclusion Criteria individuals with diaphragm paresis:

  • Age: 18-70 years old
  • Unilateral or bilateral diaphragm paresis following paresis of phrenic nerve
  • Willingness to sign the informed consent

Inclusion Criteria healthy controls:

  • Age: 18-70 years old
  • Spirometry: FEV1/FVC ≥ 0.7 and FEV1 > 80%
  • Willingness to sign the informed consent

Exclusion Criteria:

  • History of major trauma and/or major orthopedic surgery of the spine, the pelvis or the lower quadrant
  • One of the following conditions: Parkinson, multiple sclerosis, stroke, history of vestibular disorder
  • Respiratory disorder other than diaphragm paresis
  • Recent diagnosis of cancer
  • Significant cardiovascular comorbidity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01505556


Contacts
Contact: Lotte Janssens, PhD student 003216329082 lotte.janssens@faber.kuleuven.be
Contact: Simon Brumagne, PhD 003216329121 simon.brumagne@faber.kuleuven.be

Locations
Belgium
Katholieke Universiteit Leuven Not yet recruiting
Leuven, Vlaams-Brabant, Belgium, 3000
Contact: Lotte Janssens, PhD student    003216329082    lotte.janssens@faber.kuleuven.be   
Contact: Simon Brumagne, PhD    003216329121    simon.brumagne@faber.kuleuven.be   
Sub-Investigator: Lotte Janssens, PhD student         
Principal Investigator: Simon Brumagne, PhD         
Principal Investigator: Thierry Troosters, PhD         
Sponsors and Collaborators
Katholieke Universiteit Leuven
Universitaire Ziekenhuizen Leuven
Investigators
Principal Investigator: Simon Brumagne, PhD Katholieke Universiteit Leuven
Principal Investigator: Thierry Troosters, PhD Katholieke Universiteit Leuven
Principal Investigator: Wim Janssens, MD, PhD Katholieke Universiteit Leuven
Principal Investigator: Marc Decramer, MD, PhD Katholieke Universiteit Leuven

Publications:
Responsible Party: Simon Brumagne, Prof. dr. Simon Brumagne, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT01505556     History of Changes
Other Study ID Numbers: 2012_SBrumagne_DiaphParesis
1.5.104.03, G.0674.09 ( Other Grant/Funding Number: Research Foundation Flanders (FWO) )
First Posted: January 6, 2012    Key Record Dates
Last Update Posted: December 5, 2013
Last Verified: January 2012

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
Respiratory Tract Diseases